IP Library › Granted Patent US 10,676,452
Granted Patent B2
US 10,676,452 · App. 15/576,290 · Granted Jun 9, 2020

Compound for the prophylaxis or treatment of organ damage

Inventors: Adrianus Cornelis Van Der Graaf (Groningen, NL); Robert Henk Henning (Groningen, NL); Leo Edwin Deelman (Peize, NL); Gerrit Jan Willem Euverink (Haren, NL)
Assignee: Sulfateq B.V.
C07D311/72A61K31/353A61P13/12C07D405/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,676,452
App. No.
15/576,290
Granted
Jun 9, 2020
Kind
B2
Abstract

The present invention relates to compounds for prophylaxis or treatment of organ damage by restoring endothelial function and/or inhibiting reactive oxygen species production and especially to compounds for prophylaxis or treatment of diabetic kidney damage. Specifically, the present invention relates to 6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(piperazin-1-yl)methanone or N,6-dihydroxy-2,5,7,8-tetramethylchroman-2-carboxamide or a pharmaceutically acceptable salt or base thereof for use in the prophylaxis or treatment of organ damage by restoring endothelial function and/or inhibiting reactive oxygen species production and especially diabetic kidney organ damage.

Claims (4)

1. A method of treating or prophylaxis of diabetic kidney damage in a subject, comprising administering to the subject a therapeutically effective amount of a compound according to the formula (II)

(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(piperazin-1-yl)methanone

or a pharmaceutically acceptable salt or base thereof, wherein endothelial function is restored, thereby treating or prophylaxis of the diabetic kidney damage.

2. The method of treating or prophylaxis of diabetic kidney damage according to claim 1 , wherein said diabetic kidney damage is diabetic nephropathy.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2019
From: VAN DER GRAAF, ADRIANUS CORNELIS, MR; HENNING, ROBERT HENK, MR; DEELMAN, LEO EDWIN, MR; EUVERINK, GERRIT JAN WILLEM, MR
To: SULFATEQ B.V.
Reel/Frame 048146/0851 →
Priority Claims (1)
NL 2014843 · May 22, 2015 · national
Continuity (1)
Related Publication 20180170892A1 · Jun 21, 2018